ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Patent Law

: Patent Docs

Biotech/Pharma Docket

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

ADVERTISEMENTS
By James DeGiulio -- PDL BioPharma Synagis Patent Invalidated MedImmune gained major ground in its infringement and licensing dispute with PDL BioPharma after its last patent on antibodies used in the respiratory drug Synagis was found invalid. The relationship between the parties began in 1997, when PDL granted MedImmune a license to develop certain types of antibodies covered by five PDL patents. In 1998, MedImmune received approval from the FDA to market the antibody drug Synagis, which is used to prevent lower respiratory tract disease in infants and children. In December 2008, in a complaint filed in the U.S. District...

Full post as published by Patent Docs on January 21, 2011 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0137 secs (new cache)